FRA
SNY icon

Front Row Advisors’s Sanofi SNY Stock Holding History

Front Row Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-218
Closed -$10.6K – 790
2024
Q2 		$10.6K Sell
218
-418
-66% -$20.2K ﹤0.01% 556
2024
Q1 		$30.9K Buy
+636
New +$31.1K 0.01% 319
2023
Q4 		– Sell
-715
Closed -$38.4K – 757
2023
Q3 		$38.4K Sell
715
-2
-0.3% -$107 0.02% 263
2023
Q2 		$39K Sell
717
-246
-26% -$13.2K 0.02% 272
2023
Q1 		$52K Buy
963
+53
+6% +$2.58K 0.02% 243
2022
Q4 		$44K Buy
910
+80
+10% +$3.51K 0.02% 256
2022
Q3 		$32K Buy
830
+312
+60% +$13.9K 0.02% 289
2022
Q2 		$26K Buy
518
+61
+13% +$3.24K 0.01% 335
2022
Q1 		$23K Buy
457
+121
+36% +$6.25K 0.01% 392
2021
Q4 		$17K Buy
336
+113
+51% +$5.59K 0.01% 466
2021
Q3 		$11K Buy
223
+33
+17% +$1.68K ﹤0.01% 545
2021
Q2 		$10K Buy
190
+62
+48% +$3.23K ﹤0.01% 572
2021
Q1 		$6K Hold
128
– – ﹤0.01% 699
2020
Q4 		$6K Sell
128
-100
-44% -$4.93K ﹤0.01% 656
2020
Q3 		$12K Sell
228
-151
-40% -$7.77K 0.01% 472
2020
Q2 		$19K Buy
379
+49
+15% +$2.38K 0.01% 357
2020
Q1 		$15K Sell
330
-2
-0.6% -$96 0.01% 385
2019
Q4 		$17K Hold
332
– – 0.01% 357
2019
Q3 		$15K Sell
332
-2
-0.6% -$86 0.01% 371
2019
Q2 		$14K Sell
334
-64
-16% -$2.72K 0.01% 377
2019
Q1 		$18K Hold
398
– – 0.01% 338
2018
Q4 		$17K Hold
398
– – 0.01% 320
2018
Q3 		$17K Sell
398
-2
-0.5% -$85 0.01% 332
2018
Q2 		$17K Buy
400
+71
+22% +$2.79K 0.01% 359
2018
Q1 		$13K Sell
329
-5
-1% -$208 0.01% 407
2017
Q4 		$14K Buy
+334
New +$15.4K 0.01% 390

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Front Row Advisors's SNY Position: Q3 2024 in Review

Front Row Advisors sold out of Sanofi (SNY) in Q3 2024, closing a stake of 218 shares — an estimated $10.6K sold.

Front Row Advisors first reported a position in SNY in Q4 2017 and held it in 26 quarters. The position peaked at $52K in Q1 2023. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Front Row Advisors reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 218 Sanofi shares in Q3 2024, an estimated $10.6K.
  • Front Row Advisors first reported a position in Sanofi in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Sanofi position peaked at $52K in Q1 2023.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.